Antibody Therapeutics Patients First!

공지사항

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting
  • 글쓴이 관리자
  • 작성일 2019-02-07 09:34:10
  • 조회수 325

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting.

(https://www.edqm.eu/en/groups-experts-and-working-parties)

목록





이전글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
다음글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...